Trial intelligence / Profile preview

Bioequivalence of Nurofen for Children vs Algifor Junior in Healthy Adults

NCT03496324Phase 1Completed

Sponsor
Reckitt
Start
Feb 2016
Primary completion
May 2016
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of ibuprofen in pain and fever (4 arms), sponsored by Reckitt. Primary endpoints: Maximum Plasma Concentration and Area Under Plasma Concentration-time Curve From Administration to Last Quantifiable Concentration. Started Feb 2016; status: completed.

02

Drugs

ibuprofen
03

Conditions

painfever

Beyond the preview

Go deeper on NCT03496324.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03496324.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call